These findings indicate that choroidal and macular thickness measurements are associated with AS even in the absence of clinically evident uveitis, and that anti-TNF-α therapy is associated with lower choroidal thickness compared with NSAID treatment. The gene discussed is TNF; the disease is uveitis.